BENGALURU, India, Nov. 26, 2025 /PRNewswire/ -- 'Healthy childhood is the foundation on which healthy adulthood is built.' - This…
PUNE, India, Nov. 24, 2025 /PRNewswire/ -- Apollo Hospitals, Asia's pioneering integrated healthcare services provider, today inaugurated its newest facility in…
Antibody levels remained well above baseline across all six serotypes and age groups sixth month after third yearly booster doseNo…
Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare Conference Schlieren (Zürich), Switzerland, November 26, 2025 – Kuros…
Presents One-Year Outcomes from the LANDMARK Randomized Controlled TrialVAPI, India, Nov. 25, 2025 /PRNewswire/ -- Underscoring India's rising influence in…
Italian wheelchair basketball team, sponsored by Menarini, was presented to the press and public in Italy. The challenges they will…
Positive results from ianalumab pivotal Phase III trial in ITP patients previously treated with corticosteroids to be presented as late-breakerScemblix…
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous…
Data spans five abstracts including two oral presentations with important findings for patients living with blastic plasmacytoid dendritic cell neoplasm (BPDCN)BPDCN…
- Results Underscore Need for Continued Research and Diverse Treatment PipelineCHICAGO, Nov. 24, 2025 /PRNewswire/ -- The Alzheimer's Association is disappointed…